Abstract
Multiple Sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system. While individuals of all ages are affected by MS, it is more commonly diagnosed in young adults and its prevalence is significantly increased in women compared to men. More than half of women diagnosed with MS will develop the disease during their reproductive years. MS does not decrease fertility rates. However, pregnancy may have a significant effect on disease activity. The clinician has a key role in educating the patient appropriately and alleviating any concerns surrounding MS and pregnancy. It will also be necessary to consider MS treatment modification prior and during pregnancy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Buraga I, Popovici RE. Multiple sclerosis and pregnancy: current considerations. ScientificWorldJournal. 2014;2014:513160, 1.
Bove R, Rankin K, Chua AS, Saraceno T, Sattarnezhad N, Greeke E, et al. Oral contraceptives and MS disease activity in a contemporary real-world cohort. Mult Scler. 2018;24(2):227–30.
Houtchens MK, Zapata LB, Curtis KM, Whiteman MK. Contraception for women with multiple sclerosis: guidance for healthcare providers. Mult Scler. 2017;23(6):757–64.
Dobson R, Dassan P, Roberts M, Giovannoni G, Nelson-Piercy C, Brex PA. UK consensus on pregnancy in multiple sclerosis: ‘Association of British Neurologists’ guidelines. Pract Neurol. 2019;19(2):106–14.
Houtchens MK, Edwards NC, Phillips AL. Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS. Neurology. 2018;91(17):e1570–e8.
Correale J, Farez MF, Ysrraelit MC. Increase in multiple sclerosis activity after assisted reproduction technology. Ann Neurol. 2012;72(5):682–94.
Hellwig K, Schimrigk S, Beste C, Muller T, Gold R. Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. Eur Neurol. 2009;61(2):65–8.
Bove R, Rankin K, Lin C, Zhao C, Correale J, Hellwig K, et al. Effect of assisted reproductive technology on multiple sclerosis relapses: case series and meta-analysis. Mult Scler. 2019;26:1352458519865118.
Langer-Gould AM. Pregnancy and family planning in multiple sclerosis. Continuum (Minneap Minn). 2019;25(3):773–92.
Portaccio E, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M, et al. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: maternal risks. Neurology. 2018;90(10):e832–e9.
Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011;117(5):1499–506.
Coles AJ, Cohen JA, Fox EJ, Giovannoni G, Hartung HP, Havrdova E, et al. Alemtuzumab CARE-MS II 5-year follow-up: efficacy and safety findings. Neurology. 2017;89(11):1117–26.
Bonney EA. Immune regulation in pregnancy: a matter of perspective? Obstet Gynecol Clin N Am. 2016;43(4):679–98.
Houtchens MK, Edwards NC, Schneider G, Stern K, Phillips AL. Pregnancy rates and outcomes in women with and without MS in the United States. Neurology. 2018;91(17):e1559–e69.
van der Kop ML, Pearce MS, Dahlgren L, Synnes A, Sadovnick D, Sayao AL, et al. Neonatal and delivery outcomes in women with multiple sclerosis. Ann Neurol. 2011;70(1):41–50.
Ray JG, Vermeulen MJ, Bharatha A, Montanera WJ, Park AL. Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA. 2016;316(9):952–61.
Boz C, Terzi M, Zengin Karahan S, Sen S, Sarac Y, Emrah MM. Safety of IV pulse methylprednisolone therapy during breastfeeding in patients with multiple sclerosis. Mult Scler. 2018;24(9):1205–11.
Jokubaitis VG, Spelman T, Kalincik T, Lorscheider J, Havrdova E, Horakova D, et al. Predictors of long-term disability accrual in relapse-onset multiple sclerosis. Ann Neurol. 2016;80(1):89–100.
Haghikia A, Hellwig K. Multiple sclerosis. In: Neurological illness in pregnancy: principles and practice; 2016. p. 142–52.
Krysko KM, Rutatangwa A, Graves J, Lazar A, Waubant E. Association between breastfeeding and postpartum multiple sclerosis relapses: a systematic review and meta-analysis. JAMA Neurol. 2019;77:327.
O’Gorman C, Lin R, Stankovich J, Broadley SA. Modelling genetic susceptibility to multiple sclerosis with family data. Neuroepidemiology. 2013;40(1):1–12.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Balashov, K., Rosario, Y. (2023). Management of Multiple Sclerosis in Pregnancy. In: Gupta, G., et al. Neurological Disorders in Pregnancy. Springer, Cham. https://doi.org/10.1007/978-3-031-36490-7_21
Download citation
DOI: https://doi.org/10.1007/978-3-031-36490-7_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-36489-1
Online ISBN: 978-3-031-36490-7
eBook Packages: MedicineMedicine (R0)